Equities

GoodRx Holdings Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
GDRX:NSQ

GoodRx Holdings Inc

Actions
Health CareHealth Care Providers
  • Price (USD)4.75
  • Today's Change-0.155 / -3.16%
  • Shares traded1.39m
  • 1 Year change-40.91%
  • Beta1.2455
Data delayed at least 15 minutes, as of Jul 11 2025 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

GoodRx Holdings, Inc. is a platform for medication savings in the United States, used by consumers and healthcare professionals. The Company connects consumers, healthcare professionals, payers, pharmacy benefit managers (PBMs), pharma manufacturers, and retail pharmacies to make saving on medications easier. The Company's offerings include prescription marketplace and pharma manufacturer solutions. Its prescription marketplace consists of its prescription transactions offering and its supplemental subscription and telehealth offerings. Through its GoodRx Care platform, the Company offers consumers access to telehealth visits on a cash-pay basis outside of insurance. The Company partners with pharma manufacturers to advertise and integrate their affordability solutions into its platform. These solutions, provided by pharma manufacturers, include co-pay cards, patient assistance programs, care portals, and other savings options to ensure consumers can access their medications.

  • Revenue in USD (TTM)797.41m
  • Net income in USD28.45m
  • Incorporated2015
  • Employees738.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Rapid7 Inc849.16m25.37m1.48bn2.41k67.2627.9920.921.740.34180.341812.290.82150.542--6.41351,910.101.62-7.982.51-12.9170.6069.642.99-15.28----0.9466--8.5320.89116.70---13.11--
Porch Group Inc427.15m-11.07m1.49bn729.00----183.853.49-0.1573-0.15733.90-0.51470.5075--25.85585,939.60-1.87-12.91-2.75-22.3055.7355.30-3.68-34.35---1.601.08--1.75--75.49------
Diginex Ltd1.18m-6.90m1.53bn19.00------1,299.06-0.3048-0.30480.052-0.69941.18--6.0756,050.95-695.01-----------586.62-----------20.07--47.38------
Schrodinger Inc230.49m-192.21m1.54bn891.00--4.13--6.69-2.64-2.643.165.090.3113--5.20258,689.10-25.96-12.16-31.80-14.3162.6159.08-83.39-49.75----0.00---4.2119.39-559.54--31.83--
Amplitude Inc306.60m-95.09m1.58bn724.00--5.45--5.15-0.7529-0.75292.432.210.6939--7.88423,482.00-21.52-22.18-32.29-30.8074.4872.17-31.01-34.86----0.00--8.3234.32-4.38--21.63--
Phreesia Inc434.53m-42.72m1.59bn2.08k--5.63--3.66-0.7381-0.73817.474.751.13--6.15208,708.90-11.06-28.17-15.44-35.7168.0264.62-9.83-36.44---301.900.0489--17.8327.4657.24--14.35--
LegalZoom.com Inc690.78m30.35m1.61bn964.0051.988.6223.742.340.17140.17143.841.031.39--41.04716,573.606.12-5.6815.41-15.4865.5165.624.39-3.44----0.00--3.2010.80114.7440.7614.24--
Sapiens International Corporation NV544.24m72.76m1.65bn4.85k22.783.5817.903.031.301.309.698.240.7787--5.19112,213.4010.428.0314.3510.2544.3242.1613.3911.35----0.040146.955.4010.7415.5922.42-10.1920.97
Opera Ltd (ADR)523.50m84.22m1.65bn599.0025.301.7616.313.150.72890.72893.8910.510.513--6.33873,958.308.254.659.075.0169.5881.5616.0914.84----0.010272.9821.5222.22-47.3114.6721.36--
Goodrx Holdings Inc797.41m28.45m1.69bn738.0064.052.6216.462.130.07410.07412.071.810.5801--5.231,080,507.002.07-4.812.25-5.1193.8492.883.57-9.55--3.160.4286--5.6115.34284.82-24.3365.02--
Olo Inc299.11m3.27m1.71bn617.00578.622.4390.775.720.01750.01751.774.160.399--4.08484,776.300.4356-5.150.4779-5.7754.6765.581.09-15.25----0.00--24.8141.2498.46--56.50--
IQIYI Inc - ADR3.97bn40.58m1.76bn4.67k44.000.9258--0.44350.04160.04164.101.980.609830.1911.22850,367.200.6645-4.631.33-9.8023.7237.531.09-6.980.4271.730.5152---8.310.1592-60.32---57.51--
Certara Inc394.50m-2.63m1.80bn1.49k--1.6526.624.56-0.0166-0.01662.456.710.2542--4.54265,297.90-0.1692-1.60-0.1814-1.7260.2660.09-0.6654-7.19--1.230.2138--8.7013.0678.23--17.20--
Data as of Jul 11 2025. Currency figures normalised to GoodRx Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

32.07%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 20258.53m8.18%
Lakewood Capital Management LPas of 31 Mar 20254.89m4.69%
Columbia Management Investment Advisers LLCas of 31 Mar 20254.63m4.45%
Petrus Trust Co. LTAas of 31 Mar 20253.17m3.04%
Renaissance Technologies LLCas of 31 Mar 20253.01m2.89%
Dimensional Fund Advisors LPas of 31 Mar 20252.09m2.01%
Rip Road Capital Partners LPas of 31 Mar 20251.92m1.84%
8 Knots Management LLCas of 31 Mar 20251.84m1.76%
SSgA Funds Management, Inc.as of 31 Mar 20251.77m1.70%
BlackRock Fund Advisorsas of 31 Mar 20251.59m1.52%
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.